Teza Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Teza Capital Management's PFE Position: Q1 2026 in Review
Teza Capital Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 16,923 shares — an estimated $421K sold.
Teza Capital Management first reported a position in PFE in Q1 2017 and held it in 17 quarters. The position peaked at $3.96M in Q4 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Teza Capital Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Teza Capital Management sold 16,923 Pfizer shares in Q1 2026, an estimated $421K.
- Teza Capital Management first reported a position in Pfizer in Q1 2017 and held it in 17 quarters.
- Teza Capital Management's Pfizer position peaked at $3.96M in Q4 2024.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Teza Capital Management's 13F filing for Q1 2026, filed 15 May 2026.